Skip to content

Ya-Liang Zhang

  • Ph.D
  • Nanjing University
  • 5h-indexImpact measure calculated using publication and citation counts. Updated daily.
  • 85CitationsNumber of citations received by Ya-Liang's publications. Updated daily.

Research interests

flow cytometercancerCADDdrug design and discovery

Co-authors (58)

Publications (5)

  • Novel nicotinoyl pyrazoline derivates bearing N-methyl indole moiety as antitumor agents: Design, synthesis and evaluation

    • Chen K
    • Zhang Y
    • Fan J
    • et al.
    N/AReaders
    N/ACitations
    Get full text
  • Pharmacodynamic and pharmacokinetic characteristics of YMR-65, a tubulin inhibitor, in tumor-bearing mice

    • Fan A
    • Wei J
    • Yang M
    • et al.
    N/AReaders
    N/ACitations
    Get full text
  • Evaluation of the pharmacokinetics, tissue distribution and excretion studies of YMR-65, a tubulin polymerization inhibitor with potential anticancer activity, in rats using UPLC-MS/MS

    • Fan A
    • Zhang Y
    • Zhang Q
    • et al.
    N/AReaders
    N/ACitations
    Get full text
  • Design, synthesis and biological evaluation of novel 5-phenyl-1H-pyrazole derivatives as potential BRAFV600E inhibitors

    • Wang S
    • Zhu Y
    • Zhu P
    • et al.
    N/AReaders
    N/ACitations
    Get full text
  • Effect of exercise intensity on isoform-specific expressions of NT-PGC-1 alpha mRNA in mouse skeletal muscle

    • Wen X
    • Wu J
    • Chang J
    • et al.
    N/AReaders
    N/ACitations
    Get full text

Education

PhD student

Nanjing University

April 2013 - Present

Bachelor

China Pharmaceutical University

September 2008 - June 2012(4 years)